Rights Issue Offer to Raise Up To $6.6 million
Filed with ASX · · 3 pages · English
Rhythm Biosciences Limited on 6ix
In the deck
Story so far
Earlier from Rhythm Biosciences
- Quarterly Activities Report and Appendix 4C - Dec23
- Strategy & Market Update
- Platform Expansion - Lung Cancer Diagnostic Test Update
- Executive Management Changes
- Receipt of First Tranche of $1.69m in R&D Tax Incentive
Later from Rhythm Biosciences
- Prospectus - 2024 Non-Renounceable Rights Issue
- Half Yearly Report and Accounts
- S&P DJI Announces March 2024 Quarterly Rebalance
- Internationally Renowned Clinical Advisory Board Established
- Close of Rights Issue
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences